0001477932-21-003657.txt : 20210527
0001477932-21-003657.hdr.sgml : 20210527
20210527194230
ACCESSION NUMBER: 0001477932-21-003657
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161107
FILED AS OF DATE: 20210527
DATE AS OF CHANGE: 20210527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yuan William
CENTRAL INDEX KEY: 0001414910
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55908
FILM NUMBER: 21975214
MAIL ADDRESS:
STREET 1: ONE ALMEDEN BLVD, SUITE 310
CITY: SAN JOSE
STATE: CA
ZIP: 95113
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp.
CENTRAL INDEX KEY: 0001643301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371765151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
BUSINESS PHONE: 805-824-0410
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
FORMER COMPANY:
FORMER CONFORMED NAME: Makkanotti Group Corp.
DATE OF NAME CHANGE: 20150526
4
1
form4.xml
FORM 4
X0306
4
2016-11-07-05:00
true
0001643301
Cure Pharmaceutical Holding Corp.
CURR
0001414910
Yuan William
1620 BEACON PLACE
OXNARD
CA
93022
false
false
false
true
Former Director
Stock Option
0.74
2016-11-07-05:00
4
A
false
100000
0.00
A
2028-04-06-05:00
Common Stock
100000
100000
D
Stock Option
3.40
2019-01-01-05:00
4
A
false
100000
0.00
A
2029-04-11-05:00
Common Stock
100000
100000
D
Restricted Stock Unit
0.00
2020-09-23-05:00
4
A
false
61654
0.00
A
Common Stock
61654
61654
D
The option becomes exercisable on the basis determined by the equity incentive plan with 6.25% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100%. This late filing is due to an inadvertent administrative error and not any error of the reporting person.
The reporting person received restricted stock units under the equity incentive plan. Vesting occurs within a one-year term or until the next annual meeting of shareholders. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. This late filing is due to an inadvertent administrative error and not any error of the reporting person.
/s/ William Yuan
2021-05-27-05:00